Y-mAbs Therapeutics Cash from Financing (TTM) Analysis

Y-mAbs Therapeutics Inc (YMAB)

16.49 +1.26 (+8.27%) USD | NASDAQ | May 01, 16:00

16.49 0.00 (0.00%) After-Hours: 19:04

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	0.10M
September 30, 2023	0.00
June 30, 2023	0.052M
March 31, 2023	0.052M
December 31, 2022	0.084M
September 30, 2022	0.184M
June 30, 2022	0.38M
March 31, 2022	0.511M
December 31, 2021	108.31M
September 30, 2021	109.63M
June 30, 2021	109.60M

Date	Value
March 31, 2021	109.47M
December 31, 2020	2.004M
September 30, 2020	135.29M
June 30, 2020	135.07M
March 31, 2020	135.07M
December 31, 2019	134.70M
September 30, 2019	-1.842M
June 30, 2019	100.53M
March 31, 2019	100.40M
December 31, 2018	98.76M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-1.842M

Minimum

Sep 2019

135.29M

Maximum

Sep 2020

56.80M

Average

2.004M

Median

Dec 2020

Cash from Financing (TTM) Benchmarks